|
HS Code |
234634 |
| Chemical Formula | C11H10N4O2S3 |
| Molecular Weight | 326.42 g/mol |
| Appearance | Typically a solid |
| Physical State At Room Temp | Solid |
| Odor | May have a characteristic sulfur - like odor |
| Solubility In Water | Low solubility in water |
| Solubility In Organic Solvents | Soluble in some organic solvents |
| Melting Point | Data specific to compound needed |
| Boiling Point | Data specific to compound needed |
| Stability | Stable under normal conditions |
| Toxicity | Toxicological data required for full assessment |
As an accredited S-2-Benzothiazolyl (Z)-2-Amino-Alpha-(Methoxyimino)-4Thiazoleethanethioate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 1 kg of S - 2 - Benzothiazolyl (Z)-2 - Amino - Alpha-(Methoxyimino)-4 - Thiazoleethanethioate in sealed bags. |
| Shipping | The chemical "S - 2 - Benzothiazolyl (Z)-2 - Amino - Alpha-(Methoxyimino)-4 - Thiazoleethanethioate" will be shipped in sealed, corrosion - resistant containers. Shipment follows strict hazardous material regulations, ensuring secure transit. |
| Storage | Store “S - 2 - Benzothiazolyl (Z)-2 - Amino - Alpha - (Methoxyimino)-4 - Thiazoleethanethioate” in a cool, dry place away from heat sources and ignition sources. Keep it in a tightly closed container to prevent moisture absorption and exposure to air. Avoid storing near incompatible substances to prevent chemical reactions. |
Competitive S-2-Benzothiazolyl (Z)-2-Amino-Alpha-(Methoxyimino)-4Thiazoleethanethioate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
S-2-Benzothiazolyl (Z)-2-amino-alpha-(methoxyimino)-4-thiazoleethanethioate (CAS 84962-98-1), designated in batch production records as MAEM or the 2-mercaptobenzothiazolyl active ester of (Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid, functions as the penultimate acyl donor in the convergent synthesis of third-generation cephalosporins including cefotaxime sodium and ceftriaxone disodium hemiheptahydrate. The crystalline solid, routinely supplied with HPLC purity ≥ 99.0% and (Z)-isomer content ≥ 98.5%, exhibits a melting range of 138–142°C and requires storage at 2–8°C under positive nitrogen pressure to retard hydrolytic cleavage of the thioester carbonyl.
In the pivotal N-acylation of 7-aminocephalosporanic acid (7-ACA) or its 3′-derivatized intermediates, MAEM operates through a nucleophilic addition–elimination pathway facilitated by the leaving group propensity of 2-mercaptobenzothiazole (MBT). MBT departs as the thiolate with a pKa of approximately 6.9 in aqueous acetonitrile, markedly lower than that of alternative leaving groups such as 2-mercaptobenzoxazole (pKa ~7.5). This moderately acidic character permits acylation at temperatures down to −10°C under rigorously anhydrous conditions, preserving the integrity of the β-lactam ring while minimizing Δ³-to-Δ² isomerization that would otherwise reduce antimicrobial potency. A typical charge ratio of MAEM to 7-ACA is maintained between 1.08 and 1.15 molar equivalents to compensate for the consumption of activated ester by residual moisture introduced with the solid. In a 3000 L glass-lined reactor equipped with jacket circulation capable of delivering brine at −15°C, a 10% v/v solution of triethylamine in dichloromethane is metered over 90–120 min while the internal temperature is held at −5 ± 2°C. Process analytical technology (ReactIR) tracks the thioester carbonyl stretch at 1720 cm⁻¹; its disappearance coincides with complete conversion, typically achieved within 6 h post-addition as confirmed by HPLC using a C18 column (250 × 4.6 mm, 5 µm) and a phosphate buffer pH 6.8/acetonitrile 85:15 mobile phase (retention time of MAEM ~12.3 min). Excessive hold time beyond 8 h at 0°C promotes hydrolysis of the cephalosporin nucleus, detectable as the formamide derivative eluting at relative retention time 0.72.
Differences in acylation performance among common leaving groups are summarized in the following compilation of pilot-plant data. The MBT ester (MAEM) occupies a position that balances reactivity with epimerization risk, a profile that has dictated its selection over more labile esters for large-scale campaigns requiring consistent (Z)-isomer specification limits.
| Activated Ester | Leaving Group pKa | Typical Acylation Yield (%) | (E)-Isomer Generated (%) | Storage Stability at 25°C |
|---|---|---|---|---|
| 2-Mercaptobenzothiazolyl (MAEM) | 6.9 | 88–92 | ≤0.3 | 6 months (N₂, 2–8°C) |
| 2-Mercaptobenzoxazolyl (MBO ester) | 7.5 | 78–85 | 0.5–0.8 | 3 months (N₂, 2–8°C) |
| 1-Hydroxybenzotriazolyl (HOBt ester) | 4.6 (conjugate acid) | 92–96 | 1.2–2.0 | ≤1 month (desiccated, −20°C) |
| p-Nitrophenyl ester | 7.2 (leaving group alcohol) | 72–80 | ≤0.2 | 12 months (ambient, dry) |
The synthesis of MAEM from (Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid (ATMA) typically proceeds via activation with 2,2′-dibenzothiazolyl disulfide (MBTS) and triphenylphosphine in dichloromethane at 0–5°C. Under these conditions, the (Z)-configured oxime ether is vulnerable to acid-catalyzed isomerization to the (E)-form if the solution pH drifts below 4.5 during aqueous work-up. Industrial batches therefore incorporate a buffered sodium bicarbonate wash (pH 7.8–8.2) immediately after reaction quench. The crude product is recrystallized from ethyl acetate/n-hexane (1:3 v/v) to elevate the (Z)-isomer content from typical crude values of 96–97% to the release specification of ≥ 98.5%. Monitoring of polymorphic form via XRPD has shown that rapid cooling at −0.5°C/min produces the kinetically favored Form I, which exhibits higher bulk density and superior flow characteristics for automated filling lines.
Scale-up data from 50 L Hastelloy reactors to 500 L glass-lined vessels confirms that (E)-isomer content can be held at ≤ 0.3% when four conditions are strictly enforced: the slurry of MAEM is washed with pre-cooled isopropanol at 5°C immediately before filtration, the vacuum drying temperature does not exceed 40°C (chamber wall temperature set point 38°C) at a pressure ≤ 10 mbar, the drying endpoint moisture is verified as ≤ 0.2% by Karl Fischer (USP <921> Method Ia), and the dried cake is discharged under a nitrogen blanket into double-laminated foil bags containing silica gel desiccant. Deviation of the drying temperature to 45°C for only 3 h resulted in a 0.15% increase in (E)-isomer across three consecutive GMP campaigns, underscoring the narrow thermal processing window.
Retained samples stored at 25°C/60% RH for 48 h in unsealed containers exhibited an assay decline of 0.8% accompanied by a melting point depression from 141.2°C to 137.8°C, attributable to uptake of 0.6% moisture and partial hydrolysis to MBT and the free acid. The release specification matrix applied for pharmaceutical intermediate qualification is given below.
| Test Parameter | Acceptance Criterion | Analytical Method |
|---|---|---|
| Appearance | White to pale yellow crystalline powder | Visual (Ph.Eur. 2.2.1) |
| Identification | IR spectrum concordant with reference; HPLC retention time matches standard | Ph.Eur. 2.2.24; USP <621> |
| Assay (HPLC, anhydrous basis) | 99.0–101.0% | In-house HPLC-UV (272 nm) |
| (Z)-Isomer content | ≥ 98.5% | HPLC area normalization |
| (E)-Isomer content | ≤ 1.0% | HPLC area normalization |
| Water content | ≤ 0.5% | USP <921> Method Ic |
| Sulfated ash | ≤ 0.1% | Ph.Eur. 2.4.14 |
| Heavy metals (elemental impurities) | Pb ≤ 5 ppm, Cd ≤ 2 ppm, As ≤ 1.5 ppm | USP <232>/<233> |
| Residual solvents | Ethyl acetate ≤ 0.5%, n-hexane ≤ 0.029%, dichloromethane ≤ 0.06% | USP <467> Procedure A |
| Particle size (D₅₀) | 5–15 µm (jet-milled grade) | Laser diffraction (ISO 13320:2020) |
Wetted surfaces in the acylation vessel must be borosilicate glass or Hastelloy C22; prolonged contact with 316L stainless steel at the reaction pH of 7.0–7.5 has been associated with trace iron leaching that catalyzes β-lactam ring-opening when the mixture is later acidified to precipitate the cephalosporin acid. Prior to charging, the reactor is dried by a vacuum-nitrogen break cycle repeated three times until a dew point of ≤ −40°C is achieved in the outlet purge gas, corresponding to a residual moisture content of less than 0.1 ppm in the nitrogen blanket. MAEM powder is transferred via a split butterfly valve from a portable isolator conditioned to ≤ 10% RH. In campaigns where the water content of the incoming MAEM exceeds 0.3%, an additional drying step is executed inside the isolator using a nitrogen sweep at 25 ± 2°C for 4–6 h before the batch is released for use; failure to implement this step has led to yield losses of 5–8% due to premature hydrolysis during base addition.
Reaction monitoring by in-situ FTIR and offline HPLC sampling defines an acceptable endpoint window of 4–6 h. Extension of the hold time beyond 8 h at the target temperature of −5°C results in gradual accumulation of the hydrolyzed free acid (ATMA) and MBT; once the free acid exceeds 2.0 area% in the reaction mixture, subsequent isolation of the cephalosporin intermediate yields a product that fails the clarity test in water for injection (Ph.Eur. 2.2.1) due to the formation of insoluble ATMA-related residues. Process deviation investigations from three manufacturing sites have documented that a jacket temperature excursion to +2°C for 20 min during the addition phase increased the (E)-isomer in the final drug substance by 0.6%, requiring reprocessing of 120 kg of sterile cefotaxime sodium. Consequently, the batch record mandates automated interlock of the triethylamine dosing pump with the jacket temperature controller, ceasing addition if the reaction mass temperature exceeds −3°C.
Prolonged exposure to relative humidity above 40% at 25°C initiates deliquescence-like behavior at the crystal surface, generating a sticky agglomerate that resists dissolution in dichloromethane and leads to solids carryover that fouls the 0.2 µm in-line filter of the acylation feed line. The material must therefore be double-bagged in LDPE liners inside a fiber drum, with each liner individually purged and heat-sealed under nitrogen; once opened, the contents are intended for a single contiguous operation without subdivision. Contact with amine bases stronger than triethylamine—including DBU (pKa conjugate acid ~12.5), DMAP, or unhindered primary amines—triggers instantaneous and non-selective acylation that generates polymeric by-products and renders the batch irrecoverable. MAEM is classified under GHS as Skin Sensitizer Category 1 (H317) and Aquatic Chronic 3 (H412); engineering controls including local exhaust ventilation and closed-transfer systems are required to maintain airborne dust below the OEL of 0.1 mg/m³ (8-h TWA).